China Universal Asset Management »

Kura Oncology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $144k 17k 8.71
2024-09-30 $288k 15k 19.54
2024-06-30 $184k 9.0k 20.59
2024-03-31 $333k 16k 21.33
2023-12-31 $124k 8.6k 14.38
2023-09-30 $17k 1.9k 9.12
2023-06-30 $9.5k 897 10.58
2023-03-31 $11k 928 12.23
2022-12-31 $8.6k 693 12.41
2022-09-30 $9.0k 626 14.38

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Kura Oncology

BlackRock
Armistice Capital
Suvretta Capital Management
Vanguard Group
RA Capital Management
Paradigm Biocapital Advisors
EcoR1 Capital
State Street Corporation
Morgan Stanley
BVF
Millennium Management
venBio Select Advisor
Deep Track Capital
Commodore Capital
Geode Capital Management

View all funds holding Kura Oncology